FDA grants priority review to Roche’s bispecific antibody glofitamab for people with relapsed or refractory large B-cell lymphoma Read more
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030 Read more
New ’Mobilisights’ Business Unit Advances Stellantis’ Growing Data and Connected Services Offer Read more